Advisory Council for the Elimination of Tuberculosis: Notice of Charter Amendment, 89103 [2016-29453]
Download as PDF
Federal Register / Vol. 81, No. 237 / Friday, December 9, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis: Notice of Charter
Amendment
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the
Advisory Council for the Elimination of
Tuberculosis (ACET), Centers for
Disease Control and Prevention (CDC),
Department of Health and Human
Services (HHS), has amended their
charter to add a person who has had
tuberculosis disease or who is the
parent of a child who has had
tuberculosis disease. The amended
filing date is November 2, 2016.
For information, contact Hazel Dean,
Sc.D., M.P.H., Designated Federal
Officer, Advisory Council for the
Elimination of Tuberculosis,
Department of Health and Human
Services, 1600 Clifton Road NE.,
Mailstop E–10, Atlanta, Georgia 30333,
telephone 404/639–8000 or fax 404/
639–8600.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–29453 Filed 12–8–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK3G9T082PROD with NOTICES
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
8:30 a.m.–4:30 p.m., EST, January 17,
2017
VerDate Sep<11>2014
18:13 Dec 08, 2016
Jkt 241001
8:30 a.m.–11:30 a.m., EST, January 18,
2017
Place: CDC, 4770 Buford Highway,
Atlanta, Georgia 30341
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 60
people. The public is welcome to
participate during the public comment
period which in tentatively scheduled
on Tuesday, January 17, 2017 from 1:30
p.m. until 1:45 p.m., and on
Wednesday, January 18, 2017 from
10:30 a.m. until 10:45 a.m. This meeting
will also be available by teleconference.
Please dial (877) 315–6535 and enter
code 383520#.
Purpose: The Secretary, Department
of Health and Human Services (HHS)
and by delegation, the Director, CDC
and Administrator, NCEH/ATSDR, are
authorized under Section 301 (42 U.S.C.
241) and Section 311 (42 U.S.C. 243) of
the Public Health Service Act, as
amended, to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention
of infectious diseases and other
preventable conditions and in the
promotion of health and wellbeing; and
(3) train state and local personnel in
health work. The BSC, NCEH/ATSDR
provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the
Director, NCEH/ATSDR, regarding
program goals, objectives, strategies, and
priorities in fulfillment of the agency’s
mission to protect and promote people’s
health. The board provides advice and
guidance that will assist NCEH/ATSDR
in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
Matters for Discussion: The agenda
items for the BSC Meeting will include
NCEH/ATSDR Office of the Director
updates; Hydraulic Fracturing; NCEH/
ATSDR Program Responses to BSC
Guidance and Action Items; HUD’s Lead
Hazard Control Program and
Implications for a Change in the CDC
Reference Value; Update on NCEH/
ATSDR Support for Flint, Michigan;
Update on NCEH Lead Surveillance
Program; Recommendations from the
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
89103
BSC Lead Poisoning Prevention
Subcommittee; NCEH/ATSDR response
to Public Health Emergencies; Federal
Research Action Plan on Tire Crumb
Used on and Playing Fields and
Playgrounds; updates from the National
Institute of Environmental Health
Sciences, the National Institute for
Occupational Safety and Health, the
U.S. Department of Energy and the U.S.
Environmental Protection Agency.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Amanda Malasky, ORISE Fellow,
NCEH/ATSDR, 4770 Buford Highway,
Mail Stop F–45, Atlanta, Georgia 30341;
Telephone 770/488–7699; Email: yoo0@
cdc.gov. The deadline for notification of
attendance is January 13, 2017.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–29454 Filed 12–8–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) PS17–002, Understanding the
Epidemiology of Syphilis in the United
States.
TIME AND DATE: 10:00 a.m.–5:00 p.m.,
EST, January 10, 2017 (Closed).
PLACE: Teleconference.
STATUS: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law
92–463.
E:\FR\FM\09DEN1.SGM
09DEN1
Agencies
[Federal Register Volume 81, Number 237 (Friday, December 9, 2016)]
[Notices]
[Page 89103]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-29453]
[[Page 89103]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis: Notice of
Charter Amendment
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that the Advisory Council for the
Elimination of Tuberculosis (ACET), Centers for Disease Control and
Prevention (CDC), Department of Health and Human Services (HHS), has
amended their charter to add a person who has had tuberculosis disease
or who is the parent of a child who has had tuberculosis disease. The
amended filing date is November 2, 2016.
For information, contact Hazel Dean, Sc.D., M.P.H., Designated
Federal Officer, Advisory Council for the Elimination of Tuberculosis,
Department of Health and Human Services, 1600 Clifton Road NE.,
Mailstop E-10, Atlanta, Georgia 30333, telephone 404/639-8000 or fax
404/639-8600.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-29453 Filed 12-8-16; 8:45 am]
BILLING CODE 4163-18-P